USFDA concludes inspection at Unichem Laboratories’ Ghaziabad facility

United States Food and Drug Administration (USFDA) has successfully concluded the inspection at Unichem Laboratories’ Ghaziabad facility. The regulator had conducted inspection at the company’s facility from March 05, 2019 to March 08, 2019. The inspection was concluded without any FDA form 483 issued.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world.

Leave a Reply

Your email address will not be published. Required fields are marked *